Kala Bioincis A Clinical Stage Biopharmaceutical Company Based In Arlingtonmassachusettsfounded In 2009The Company Focuses On Developing Innovative Therapies For Rare And Severe Eye Diseasesit Was Previously Known As Kala Pharmaceuticalsincand Changed Its Name In August 2023 Kala Bio Is Engaged In The Researchdevelopmentand Commercialization Of Treatments For Eye Conditionsits Product Pipeline Includes Kpi 012Which Is Currently In Phase 2B Clinical Trials For Persistent Corneal Epithelial Defectsand Kpi 014A Preclinical Product Aimed At Rare Inherited Retinal Diseasesthe Company Is Committed To Addressing Serious Eye Conditions Through Advanced Scientific Approacheskala Bio Is Listed On The Nasdaq Under The Ticker Symbol Kala And Has A Workforce Of Approximately 38 Employees
No conferences found for this company.
| Company Name | Kala Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
